PDB Short entry for 2L33 HEADER TRANSCRIPTION REGULATOR 03-SEP-10 2L33 TITLE SOLUTION NMR STRUCTURE OF DRBM 2 DOMAIN OF INTERLEUKIN ENHANCER- TITLE 2 BINDING FACTOR 3 FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS TITLE 3 CONSORTIUM TARGET HR4527E COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN ENHANCER-BINDING FACTOR 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DRBM 2 DOMAIN RESIDUES 521-600; COMPND 5 SYNONYM: NUCLEAR FACTOR OF ACTIVATED T-CELLS 90 KDA, NF-AT-90, COMPND 6 DOUBLE-STRANDED RNA-BINDING PROTEIN 76, DRBP76, TRANSLATIONAL CONTROL COMPND 7 PROTEIN 80, TCP80, NUCLEAR FACTOR ASSOCIATED WITH DSRNA, NFAR, M- COMPND 8 PHASE PHOSPHOPROTEIN 4, MPP4; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ILF3, DRBF, MPHOSPH4, NF90; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+ MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET 14-15C KEYWDS STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG), KEYWDS 2 PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, DRBM, DSRNA-BINDING, KEYWDS 3 ILF3, NF90, TRANSCRIPTION REGULATOR EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.LIU,H.JANJUA,R.XIAO,T.B.ACTON,A.CICCOSANTI,R.B.SHASTRY,J.EVERETT, AUTHOR 2 G.T.MONTELIONE,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM,NORTHEAST AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 3 14-JUN-23 2L33 1 DBREF REVDAT 2 05-FEB-20 2L33 1 REMARK SEQADV REVDAT 1 22-SEP-10 2L33 0 JRNL AUTH G.LIU,H.JANJUA,R.XIAO,T.B.ACTON,J.EVERETT,G.T.MONTELIONE JRNL TITL NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR4527E JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, CYANA 3.0, AUTOSTRUCTURE 2.1 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 HUANG, TEJERO, POWERS AND MONTELIONE REMARK 3 (AUTOSTRUCTURE) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2L33 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000101895. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.7 MM [U-100% 13C; U-100% 15N] REMARK 210 HR4527E, 95% H2O/5% D2O; 0.7 MM REMARK 210 [U-5% 13C; U-100% 15N] HR4527E, REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D CBCA(CO)NH; 3D REMARK 210 HNCACB; 3D 1H-13C AROM NOESY; 3D REMARK 210 SIMUTANEOUS 13C-AROMATIC,13C- REMARK 210 ALIPHATIC,15N EDITED 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS, CYANA 3.0, AUTOSTRUCTURE REMARK 210 2.1, AUTOASSIGN 2.1, NMRPIPE, REMARK 210 XEASY, TOPSPIN, VNMRJ, TALOS+ REMARK 210 METHOD USED : DISTANCE GEOMETRY, MOLECULAR REMARK 210 DYNAMICS, TORSION ANGLE DYNAMICS, REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 7 99.29 -54.29 REMARK 500 1 LEU A 12 -108.84 -123.77 REMARK 500 1 THR A 13 -168.47 -169.91 REMARK 500 1 ASN A 18 119.09 66.63 REMARK 500 1 PRO A 84 -163.40 -63.39 REMARK 500 2 THR A 13 -155.89 -101.53 REMARK 500 2 ASN A 18 117.61 62.86 REMARK 500 2 SER A 41 -46.89 73.84 REMARK 500 2 ASP A 43 161.28 65.83 REMARK 500 2 ALA A 89 78.69 -109.85 REMARK 500 3 ASN A 18 115.92 69.22 REMARK 500 3 ARG A 45 86.01 -156.32 REMARK 500 3 SER A 62 -87.90 55.19 REMARK 500 3 ASP A 82 -68.99 67.03 REMARK 500 3 ALA A 86 -168.84 -118.04 REMARK 500 3 ASP A 88 92.16 -67.70 REMARK 500 3 ASN A 90 95.29 -65.43 REMARK 500 4 LYS A 14 -162.45 -121.28 REMARK 500 4 ASN A 18 119.37 64.29 REMARK 500 4 HIS A 42 -28.14 173.64 REMARK 500 4 ASP A 43 171.40 -57.12 REMARK 500 4 ASN A 90 97.31 -66.18 REMARK 500 5 THR A 13 -86.39 36.57 REMARK 500 5 LYS A 14 -12.18 -140.51 REMARK 500 5 ASN A 18 117.99 63.52 REMARK 500 5 SER A 41 31.34 -81.86 REMARK 500 5 HIS A 42 -6.01 69.78 REMARK 500 5 ASP A 82 -72.33 62.99 REMARK 500 6 ASN A 18 126.22 62.79 REMARK 500 6 SER A 41 -41.07 -144.85 REMARK 500 6 ASP A 82 -49.58 71.96 REMARK 500 7 HIS A 15 99.10 -54.12 REMARK 500 7 ASN A 18 115.66 64.57 REMARK 500 7 ASP A 53 -5.88 68.58 REMARK 500 7 ASP A 82 -11.88 69.36 REMARK 500 7 ALA A 89 88.34 -67.50 REMARK 500 7 ASN A 90 86.67 61.68 REMARK 500 8 HIS A 4 40.46 -82.51 REMARK 500 8 THR A 13 -164.35 -126.24 REMARK 500 8 LYS A 17 34.73 -84.40 REMARK 500 8 ASN A 18 136.07 61.67 REMARK 500 8 ASP A 53 17.80 58.99 REMARK 500 8 ASP A 82 -26.92 72.23 REMARK 500 9 HIS A 7 -1.48 64.52 REMARK 500 9 LYS A 14 -30.40 72.87 REMARK 500 9 LYS A 17 20.30 -79.42 REMARK 500 9 ASN A 18 132.60 69.07 REMARK 500 10 HIS A 10 114.67 -164.59 REMARK 500 10 LYS A 14 -72.77 62.78 REMARK 500 10 ASN A 18 127.37 64.24 REMARK 500 REMARK 500 THIS ENTRY HAS 110 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17169 RELATED DB: BMRB REMARK 900 SHIFTS REMARK 900 RELATED ID: HR4527E RELATED DB: TARGETDB DBREF 2L33 A 12 91 UNP Q12906 ILF3_HUMAN 521 600 SEQADV 2L33 MET A 1 UNP Q12906 EXPRESSION TAG SEQADV 2L33 GLY A 2 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 3 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 4 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 5 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 6 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 7 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 8 UNP Q12906 EXPRESSION TAG SEQADV 2L33 SER A 9 UNP Q12906 EXPRESSION TAG SEQADV 2L33 HIS A 10 UNP Q12906 EXPRESSION TAG SEQADV 2L33 MET A 11 UNP Q12906 EXPRESSION TAG SEQRES 1 A 91 MET GLY HIS HIS HIS HIS HIS HIS SER HIS MET LEU THR SEQRES 2 A 91 LYS HIS GLY LYS ASN PRO VAL MET GLU LEU ASN GLU LYS SEQRES 3 A 91 ARG ARG GLY LEU LYS TYR GLU LEU ILE SER GLU THR GLY SEQRES 4 A 91 GLY SER HIS ASP LYS ARG PHE VAL MET GLU VAL GLU VAL SEQRES 5 A 91 ASP GLY GLN LYS PHE GLN GLY ALA GLY SER ASN LYS LYS SEQRES 6 A 91 VAL ALA LYS ALA TYR ALA ALA LEU ALA ALA LEU GLU LYS SEQRES 7 A 91 LEU PHE PRO ASP THR PRO LEU ALA LEU ASP ALA ASN LYS HELIX 1 1 ASN A 18 ARG A 27 1 10 HELIX 2 2 ASN A 63 PHE A 80 1 18 SHEET 1 A 3 LYS A 31 GLY A 39 0 SHEET 2 A 3 LYS A 44 VAL A 52 -1 O VAL A 47 N ILE A 35 SHEET 3 A 3 GLN A 55 GLY A 61 -1 O GLN A 55 N VAL A 52 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000